| Joshua D Reagan, MD | |
|
10330 Se 32nd Ave, Suite 205, Milwaukie, OR 97222-6594 | |
| (503) 513-8950 | |
| (503) 772-4337 |
| Full Name | Joshua D Reagan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 10330 Se 32nd Ave, Milwaukie, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124093281 | NPI | - | NPPES |
| 0186583 | Other | WA | WA DEPT. OF L&I |
| 226869 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD23905 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Milwaukie Hospital | Milwaukie, OR | Hospital |
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
Drugs produced in offshore manufacturing plants - even those run by U.S. manufacturers - pose a greater quality risk than those prepared in the mainland United States, a new study suggests.
Researchers at the University of Illinois at Chicago College of Medicine have developed a transgenic mouse that carries a human gene known to increase risk of Alzheimer's 15-fold. This new mouse mimics the genetics of the human disease more closely than any of the dozen existing mouse models and may prove more useful in the development of candidate drugs to prevent or treat the disease.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
With being overweight or obese one of the leading risk factors for illness and death in Australia, a new report by Australia's national science agency has shown that self-monitoring and personal accountability could be key to losing weight.
› Verified 9 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
Drugs produced in offshore manufacturing plants - even those run by U.S. manufacturers - pose a greater quality risk than those prepared in the mainland United States, a new study suggests.
Researchers at the University of Illinois at Chicago College of Medicine have developed a transgenic mouse that carries a human gene known to increase risk of Alzheimer's 15-fold. This new mouse mimics the genetics of the human disease more closely than any of the dozen existing mouse models and may prove more useful in the development of candidate drugs to prevent or treat the disease.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
With being overweight or obese one of the leading risk factors for illness and death in Australia, a new report by Australia's national science agency has shown that self-monitoring and personal accountability could be key to losing weight.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua D Reagan, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Joshua D Reagan, MD 10330 Se 32nd Ave, Suite 205, Milwaukie, OR 97222-6594 Ph: (503) 513-8950 |
News Archive
Drugs produced in offshore manufacturing plants - even those run by U.S. manufacturers - pose a greater quality risk than those prepared in the mainland United States, a new study suggests.
Researchers at the University of Illinois at Chicago College of Medicine have developed a transgenic mouse that carries a human gene known to increase risk of Alzheimer's 15-fold. This new mouse mimics the genetics of the human disease more closely than any of the dozen existing mouse models and may prove more useful in the development of candidate drugs to prevent or treat the disease.
Rhythm announced today the award of a $1 million research grant from the FDA Office of Orphan Products Development to its subsidiary, Rhythm Metabolic, Inc., to support the ongoing Phase 2 clinical trial of setmelanotide, the company's novel peptide MC4 agonist, for the treatment of obesity and hyperphagia in Prader-Willi syndrome (PWS).
With being overweight or obese one of the leading risk factors for illness and death in Australia, a new report by Australia's national science agency has shown that self-monitoring and personal accountability could be key to losing weight.
› Verified 9 days ago
Johanna Beth Warren, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10330 Se 32nd Ave, Suite 205, Milwaukie, OR 97222 Phone: 503-513-8950 | |
Dr. Jerrold L Snow, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6564 Se Lake Rd Ste 200, Milwaukie, OR 97222 Phone: 503-908-5880 Fax: 888-475-8729 | |
Rachelle Kirsten Sherard, LPN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10330 Se 32nd Ave, Milwaukie, OR 97222 Phone: 503-513-1300 | |
Dr. Jennifer Dawn Herber, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3033 Se Monroe St, Milwaukie, OR 97222 Phone: 503-659-4988 Fax: 503-659-4730 | |
William R Gillanders, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10330 Se 32nd Ave, Suite 205, Milwaukie, OR 97222 Phone: 503-513-8950 Fax: 503-513-8951 | |
Mrs. Elizabeth E. Callaghan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3033 Se Monroe St, Milwaukie, OR 97222 Phone: 503-659-4988 Fax: 503-659-4730 |